Literature DB >> 19712771

CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge.

Nathan W Schmidt1, Noah S Butler, John T Harty.   

Abstract

Individuals living in malaria endemic areas are subject to repeated infections yet fail to develop sterilizing immunity, however, immunization of mice with attenuated sporozoites or subunit vaccines has shown the ability to protect mice against a sporozoite challenge. We recently reported that mice primed with dendritic cells coated with the dominant circumsporozoite CD8 T cell epitope from Plasmodium berghei followed by a boost with recombinant Listeria monocytogenes expressing the same epitope exhibited sterile immunity against a sporozoite challenge for more than one year. In this report we show those mice do not contain protective antibodies and that depletion of CD4 T cells in the immunized mice did not affect sterile immunity. In contrast, CD8 T cell depletion eliminated protection. Thus, protective immunity generated by this immunization approach is entirely memory CD8 T cell-dependent. We also show here that mice initially protected by circumsporozoite-specific memory CD8 T cells develop sterilizing sporozoite-specific antibodies after repeated asymptomatic challenges with physiologic numbers of viable sporozoites. Therefore, initial protection by a CD8 T cell-targeted liver stage subunit vaccine allows the generation of enhanced sterilizing immune responses from repeated exposure to Plasmodium parasites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712771      PMCID: PMC2759845          DOI: 10.1016/j.vaccine.2009.08.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  T cells as mediators of protective immunity against liver stages of Plasmodium.

Authors:  Moriya Tsuji; Fidel Zavala
Journal:  Trends Parasitol       Date:  2003-02

2.  The complexity of protective immunity against liver-stage malaria.

Authors:  D L Doolan; S L Hoffman
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

3.  Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.

Authors:  L Schofield; J Villaquiran; A Ferreira; H Schellekens; R Nussenzweig; V Nussenzweig
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

5.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.

Authors:  J Schneider; S C Gilbert; T J Blanchard; T Hanke; K J Robson; C M Hannan; M Becker; R Sinden; G L Smith; A V Hill
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

Review 6.  Malaria in 2002.

Authors:  Brian Greenwood; Theonest Mutabingwa
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

7.  Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.

Authors:  S Li; M Rodrigues; D Rodriguez; J R Rodriguez; M Esteban; P Palese; R S Nussenzweig; F Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.

Authors:  Richard J Anderson; Carolyn M Hannan; Sarah C Gilbert; Stephen M Laidlaw; Eric G Sheu; Simone Korten; Robert Sinden; Geoffrey A Butcher; Michael A Skinner; Adrian V S Hill
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

9.  Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Authors:  Nathan W Schmidt; Rebecca L Podyminogin; Noah S Butler; Vladimir P Badovinac; Brad J Tucker; Keith S Bahjat; Peter Lauer; Arturo Reyes-Sandoval; Claire L Hutchings; Anne C Moore; Sarah C Gilbert; Adrian V Hill; Lyric C Bartholomay; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

10.  Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model.

Authors:  Deng Tao; Giovanna Barba-Spaeth; Urvashi Rai; Victor Nussenzweig; Charles M Rice; Ruth S Nussenzweig
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

View more
  16 in total

1.  Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults.

Authors:  Chintana Phawong; Collins Ouma; Piyatida Tangteerawatana; Jarinee Thongshoob; Tom Were; Yuvadee Mahakunkijcharoen; Duangrurdee Wattanasirichaigoon; Douglas Jay Perkins; Srisin Khusmith
Journal:  Immunogenetics       Date:  2010-04-13       Impact factor: 2.846

2.  Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.

Authors:  Kathrin Kastenmüller; Diego A Espinosa; Lauren Trager; Cristina Stoyanov; Andres M Salazar; Santosh Pokalwar; Sanjay Singh; Sheetij Dutta; Christian F Ockenhouse; Fidel Zavala; Robert A Seder
Journal:  Infect Immun       Date:  2012-12-28       Impact factor: 3.441

3.  Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.

Authors:  Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

4.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

5.  Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites.

Authors:  Nathan W Schmidt; Noah S Butler; Vladimir P Badovinac; John T Harty
Journal:  PLoS Pathog       Date:  2010-07-15       Impact factor: 6.823

Review 6.  A retrospective evaluation of the role of T cells in the development of malaria vaccine.

Authors:  Moriya Tsuji
Journal:  Exp Parasitol       Date:  2009-11-26       Impact factor: 2.011

Review 7.  The march toward malaria vaccines.

Authors:  Stephen L Hoffman; Johan Vekemans; Thomas L Richie; Patrick E Duffy
Journal:  Vaccine       Date:  2015-08-29       Impact factor: 3.641

8.  Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus.

Authors:  Bram Slütter; Lecia L Pewe; Susan M Kaech; John T Harty
Journal:  Immunity       Date:  2013-11-14       Impact factor: 31.745

Review 9.  The March Toward Malaria Vaccines.

Authors:  Stephen L Hoffman; Johan Vekemans; Thomas L Richie; Patrick E Duffy
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

10.  Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.

Authors:  Noah S Butler; Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2010-01-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.